Skip to main content
Premium Trial:

Request an Annual Quote

Biofortuna, Abbott Extend Distribution Deal

NEW YORK (GenomeWeb News) – Liverpool, UK-based Biofortuna announced today that it has extended an exclusive distribution agreement with Abbott.

Under the new agreement, Abbott will distribute Biofortuna's SSPGo range of freeze dried HLA typing kits in France, Spain, Portugal, and the Benelux countries. With this new agreement, Abbott now has exclusive rights to distribute the kits, along with the Verdict interpretation software, in all global territories.

The firms inked the initial distribution pact last year, but at that time the deal excluded the territories covered in the agreement announced today.

Biofortuna's freeze-drying capabilities enable PCR diagnostic kits to be stable at ambient temperature for up to 16 months.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.